Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Oct;83(8):1047–1054. doi: 10.1054/bjoc.2000.1420

Identification of genes differentially expressed in association with acquired cisplatin resistance

A Johnsson 3, I Zeelenberg 3, Y Min 1, J Hilinski 1, C Berry 3, S B Howell 2,3, G Los 1,3
PMCID: PMC2363570  PMID: 10993653

Abstract

The goal of this study was to identify genes whose mRNA levels are differentially expressed in human cells with acquired cisplatin (cDDP) resistance. Using the parental UMSCC10b head and neck carcinoma cell line and the 5.9-fold cDDP-resistant subline, UMSCC10b/Pt-S15, two suppressive subtraction hybridization (SSH) cDNA libraries were prepared. One library represented mRNAs whose levels were increased in the cDDP resistant variant (the UP library), the other one represented mRNAs whose levels were decreased in the resistant cells (the DOWN library). Arrays constructed with inserts recovered from these libraries were hybridized with SSH products to identify truly differentially expressed elements. A total of 51 cDNA fragments present in the UP library and 16 in the DOWN library met the criteria established for differential expression. The sequences of 87% of these cDNA fragments were identified in Genbank. Among the mRNAs in the UP library that were frequently isolated and that showed high levels of differential expression were cytochrome oxidase I, ribosomal protein 28S, elongation factor 1α, α-enolase, stathmin, and HSP70. The approach taken in this study permitted identification of many genes never before linked to the cDDP-resistant phenotype. © 2000 Cancer Research Campaign

Keywords: cisplatin resistance, suppression subtractive hybridization, high throughput screening, gene expression

Full Text

The Full Text of this article is available as a PDF (97.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alaoui-Jamali M. A., Paterson J., Al Moustafa A. E., Yen L. The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications. Biochem Cell Biol. 1997;75(4):315–325. [PubMed] [Google Scholar]
  2. Andrews P. A., Albright K. D. Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Cancer Res. 1992 Apr 1;52(7):1895–1901. [PubMed] [Google Scholar]
  3. Ara G., Kusumoto T., Korbut T. T., Cullere-Luengo F., Teicher B. A. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement. Cancer Res. 1994 Mar 15;54(6):1497–1502. [PubMed] [Google Scholar]
  4. Chao A. Estimating the population size for capture-recapture data with unequal catchability. Biometrics. 1987 Dec;43(4):783–791. [PubMed] [Google Scholar]
  5. Chatterjee D., Liu C. J., Northey D., Teicher B. A. Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors. Cancer Chemother Pharmacol. 1995;35(5):423–431. doi: 10.1007/s002800050257. [DOI] [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Diatchenko L., Lau Y. F., Campbell A. P., Chenchik A., Moqadam F., Huang B., Lukyanov S., Lukyanov K., Gurskaya N., Sverdlov E. D. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6025–6030. doi: 10.1073/pnas.93.12.6025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fink D., Nebel S., Aebi S., Zheng H., Cenni B., Nehmé A., Christen R. D., Howell S. B. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 1996 Nov 1;56(21):4881–4886. [PubMed] [Google Scholar]
  9. Green D. R., Reed J. C. Mitochondria and apoptosis. Science. 1998 Aug 28;281(5381):1309–1312. doi: 10.1126/science.281.5381.1309. [DOI] [PubMed] [Google Scholar]
  10. Hedrick S. M., Cohen D. I., Nielsen E. A., Davis M. M. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature. 1984 Mar 8;308(5955):149–153. doi: 10.1038/308149a0. [DOI] [PubMed] [Google Scholar]
  11. Hubank M., Schatz D. G. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 1994 Dec 25;22(25):5640–5648. doi: 10.1093/nar/22.25.5640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Krause C. J., Carey T. E., Ott R. W., Hurbis C., McClatchey K. D., Regezi J. A. Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch Otolaryngol. 1981 Nov;107(11):703–710. doi: 10.1001/archotol.1981.00790470051012. [DOI] [PubMed] [Google Scholar]
  13. Kuang W. W., Thompson D. A., Hoch R. V., Weigel R. J. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res. 1998 Feb 15;26(4):1116–1123. doi: 10.1093/nar/26.4.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Los G., Muggia F. M. Platinum resistance. Experimental and clinical status. Hematol Oncol Clin North Am. 1994 Apr;8(2):411–429. [PubMed] [Google Scholar]
  15. Marth C., Widschwendter M., Kaern J., Jørgensen N. P., Windbichler G., Zeimet A. G., Tropé C., Daxenbichler G. Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells. Br J Cancer. 1997;76(10):1328–1332. doi: 10.1038/bjc.1997.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Miyake H., Hanada N., Nakamura H., Kagawa S., Fujiwara T., Hara I., Eto H., Gohji K., Arakawa S., Kamidono S. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. Oncogene. 1998 Feb 19;16(7):933–943. doi: 10.1038/sj.onc.1201602. [DOI] [PubMed] [Google Scholar]
  17. Schummer M., Ng W., Nelson P. S., Bumgarner R. E., Hood L. Inexpensive handheld device for the construction of high-density nucleic acid arrays. Biotechniques. 1997 Dec;23(6):1087–1092. doi: 10.2144/97236st06. [DOI] [PubMed] [Google Scholar]
  18. Tedder T. F., Streuli M., Schlossman S. F., Saito H. Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc Natl Acad Sci U S A. 1988 Jan;85(1):208–212. doi: 10.1073/pnas.85.1.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Velculescu V. E., Zhang L., Vogelstein B., Kinzler K. W. Serial analysis of gene expression. Science. 1995 Oct 20;270(5235):484–487. doi: 10.1126/science.270.5235.484. [DOI] [PubMed] [Google Scholar]
  20. Yamada-Okabe T., Yamada-Okabe H., Kashima Y., Doi R. Effects of oncogenes on the resistance to cis-diamminedichloroplatinum(II) and metallothionein gene expression. Toxicol Appl Pharmacol. 1995 Aug;133(2):233–238. doi: 10.1006/taap.1995.1146. [DOI] [PubMed] [Google Scholar]
  21. Yang G. P., Ross D. T., Kuang W. W., Brown P. O., Weigel R. J. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res. 1999 Mar 15;27(6):1517–1523. doi: 10.1093/nar/27.6.1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Zhang L., Zhou W., Velculescu V. E., Kern S. E., Hruban R. H., Hamilton S. R., Vogelstein B., Kinzler K. W. Gene expression profiles in normal and cancer cells. Science. 1997 May 23;276(5316):1268–1272. doi: 10.1126/science.276.5316.1268. [DOI] [PubMed] [Google Scholar]
  23. Zhou W., Sokoll L. J., Bruzek D. J., Zhang L., Velculescu V. E., Goldin S. B., Hruban R. H., Kern S. E., Hamilton S. R., Chan D. W. Identifying markers for pancreatic cancer by gene expression analysis. Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):109–112. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES